Protective effect of adenosine receptor agonists in a new model of epilepsy--seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice

Neurosci Lett. 2001 Jun 8;305(2):91-4. doi: 10.1016/s0304-3940(01)01816-x.

Abstract

The role of adenosine receptor agonists in the convulsant activity of mitochondrial toxin, 3-nitropropionic acid (3-NPA), was studied in mice. The occurrence of seizures evoked by peripheral application of 3-NPA was inhibited with the use of A1 adenosine receptor agonist, R-N6-phenylisopropyladenosine and A1/A2 agonist, 2-chloroadenosine. Moreover, both drugs prevented 3-NPA-induced mortality. Similarly, A1/A2 agonist, 5'-N-ethylcarboxamidoadenosine, protected against seizures evoked by the intracerebral administration of 3-NPA, and this effect was reversed by the co-application of adenosine receptor antagonist, 8-(p-sulfophenyl)theophylline. Obtained results suggest that A1 adenosine receptor activation may modulate the chain of events leading to the development of 3-NPA-induced seizures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Chloroadenosine / pharmacology
  • Adenosine-5'-(N-ethylcarboxamide) / pharmacology
  • Animals
  • Convulsants
  • Epilepsy / chemically induced*
  • Epilepsy / prevention & control*
  • Hormone Antagonists / pharmacology
  • Male
  • Mice
  • Mitochondria / drug effects
  • Neuroprotective Agents / pharmacology*
  • Nitro Compounds
  • Phenylisopropyladenosine / pharmacology
  • Propionates* / pharmacology
  • Purinergic P1 Receptor Agonists*
  • Purinergic P1 Receptor Antagonists
  • Theophylline / analogs & derivatives*
  • Theophylline / pharmacology

Substances

  • Convulsants
  • Hormone Antagonists
  • Neuroprotective Agents
  • Nitro Compounds
  • Propionates
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • 2-Chloroadenosine
  • Phenylisopropyladenosine
  • Adenosine-5'-(N-ethylcarboxamide)
  • 8-(4-sulfophenyl)theophylline
  • Theophylline
  • 3-nitropropionic acid